Stockholders' equity - Schedule of equity awards (Detail) - Employee stock option - $ / shares |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock Options,Outstanding, beginning of period | 702,064 | 702,064 | |
| Stock Options, Granted | 36,000 | ||
| Stock Options, Outstanding, end of period | 738,064 | 702,064 | 702,064 |
| Stock Options, Exercisable, end of period | 229,333 | ||
| Exercise price, beginning of period | $ 7.16 | $ 7.16 | |
| Weighted-average Exercise Price, Granted | 2.99 | ||
| Weighted-average Exercise Price, Exercise price, end of period | 6.95 | $ 7.16 | $ 7.16 |
| Weighted-average Exercise Price, Exercisable, end of period | $ 13.59 | ||
| Weighted-average Remaining Contractual Term, Outstanding | 7 years 8 months 4 days | 7 years 9 months 25 days | 8 years 25 days |
| Weighted-average Remaining Contractual Term, Exercisable | 7 years 2 months 12 days | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|